FDA approves sorafenib for patients with inoperable liver cancer
- PMID: 18242200
- DOI: 10.1053/j.gastro.2007.12.037
FDA approves sorafenib for patients with inoperable liver cancer
Similar articles
-
Sorafenib for the treatment of unresectable hepatocellular carcinoma.Oncologist. 2009 Jan;14(1):95-100. doi: 10.1634/theoncologist.2008-0185. Epub 2009 Jan 14. Oncologist. 2009. PMID: 19144678 Review.
-
Sorafenib in hepatocellular carcinoma: separating the hype from the hope.J Clin Oncol. 2008 Dec 20;26(36):5845-8. doi: 10.1200/JCO.2008.19.7996. Epub 2008 Nov 24. J Clin Oncol. 2008. PMID: 19029408 No abstract available.
-
Sorafenib: new indication. For some patients with liver cancer.Prescrire Int. 2009 Apr;18(100):59. Prescrire Int. 2009. PMID: 19585718
-
[Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations].Gastroenterol Clin Biol. 2008 Jan;32(1 Pt. 1):3-7. doi: 10.1016/j.gcb.2007.11.001. Epub 2008 Mar 4. Gastroenterol Clin Biol. 2008. PMID: 18341970 French. No abstract available.
-
Current problems with systemic treatment of advanced hepatocellular cancer.Curr Probl Cancer. 2010 Mar-Apr;34(2):131-49. doi: 10.1016/j.currproblcancer.2010.03.001. Curr Probl Cancer. 2010. PMID: 20417353 Review. No abstract available.
Cited by
-
Three-Dimensional Hepatocyte Spheroids: Model for Assessing Chemotherapy in Hepatocellular Carcinoma.Biomedicines. 2024 May 28;12(6):1200. doi: 10.3390/biomedicines12061200. Biomedicines. 2024. PMID: 38927406 Free PMC article.
-
Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.Int J Mol Sci. 2022 Mar 29;23(7):3778. doi: 10.3390/ijms23073778. Int J Mol Sci. 2022. PMID: 35409139 Free PMC article. Review.
-
Utilization of Existing Human Kinase Inhibitors as Scaffolds in the Development of New Antimicrobials.Antibiotics (Basel). 2023 Sep 7;12(9):1418. doi: 10.3390/antibiotics12091418. Antibiotics (Basel). 2023. PMID: 37760715 Free PMC article. Review.
-
Design of a liver cancer-specific selector for the analysis of circulating tumor DNA.Oncol Lett. 2019 Jun;17(6):5369-5376. doi: 10.3892/ol.2019.10243. Epub 2019 Apr 12. Oncol Lett. 2019. PMID: 31186754 Free PMC article.
-
Chemoprotective and chemosensitizing effects of apigenin on cancer therapy.Cancer Cell Int. 2021 Oct 29;21(1):574. doi: 10.1186/s12935-021-02282-3. Cancer Cell Int. 2021. PMID: 34715860 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical